➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Johnson and Johnson
Harvard Business School
Express Scripts
AstraZeneca

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) and what is the scope of freedom to operate?

Triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) is the generic ingredient in five branded drugs marketed by Cosette, Ortho Mcneil Pharm, Alpharma Us Pharms, Fougera, Perrigo New York, Savage Labs, and Pharmaderm, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole).

Summary for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)
US Patents:0
Tradenames:5
Applicants:7
NDAs:9
Drug Master File Entries: 5
DailyMed Link:triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) at DailyMed

US Patents and Regulatory Information for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 087864-001 Sep 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Fougera TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 086424-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Cosette GYNE-SULF triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 088607-001 Jun 9, 1986 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Fougera TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) TABLET;VAGINAL 088463-001 Jan 3, 1985 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Express Scripts
Mallinckrodt
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.